v3.25.2
Related Party Transactions (Details Narrative) - USD ($)
3 Months Ended
Sep. 30, 2024
Aug. 15, 2024
Apr. 08, 2024
Aug. 30, 2023
Aug. 15, 2023
May 03, 2023
Jun. 30, 2025
Non compensatory options acquire           8,000,000  
Common stock exercise price per share           $ 0.25  
Common stock voting rights thresold percentage   29.90%          
Series E PIPE Investor [Member]              
Consideration recieved per transaction         $ 20,000,000.0    
Sale of stock         39,614    
Warrants to purchase shares of Common Stock         8,000,000    
Exercise price         $ 6.00    
Subordinated Promissory Note and Subordinated Note Warrants [Member]              
Principal amount $ 5,000,000.0            
Maturity date Mar. 17, 2027            
Subordinated Promissory Note and Subordinated Note Warrants [Member] | Maximum [Member]              
Purchase of common stock shares 1,141,552            
Series D Preferred Stock [Member] | Jonathan H Gary [Member]              
Issuance of Series D Preferred Stock to PIPE investors, net of issuance costs     $ 750,000        
Series D Preferred Stock and D Pipe Warrants [Member] | Jonathan H Gary [Member]              
Issuance of Series D Preferred Stock to PIPE investors, net of issuance costs     254,875        
Series E Preferred Stock [Member]              
Sale of stock         20,000    
Rose Hill Holdings Limited [Member]              
Non compensatory options acquire 800,000            
Bristol Investment Fund Ltd [Member] | Series D Preferred Stock [Member]              
Issuance of Series D Preferred Stock to PIPE investors, net of issuance costs     $ 1,250,000        
Noncompensatory Option Purchase Agreement [Member]              
Issuance of Common Stock to fund Bayswater Acquisition, net of issuance costs, shares 800,000     200,000     283,870
Common stock exercise price per share $ 0.25     $ 0.25      
Consent Agreement [Member]              
Related party transaction description of transaction   the Company entered into a Consent and Agreement (the “Consent and Agreement”) with the O’Neill Trust, pursuant to which the O’Neill Trust (a) consented to, and waived any and all negative covenants with respect to, any and all transactions the Company may consummate in connection with the funding of the NRO Acquisition and its ongoing operations; (b) released its mortgage on certain property of the Company, which was established in favor of the O’Neill Trust securing the Company’s obligations under the Series E Certificate; and (c) agreed to (i) amend Section 6(d) of the Series E Certificate to increase the Beneficial Ownership Limitation Ceiling from 9.99% to 49.9%, (ii) subject to consent from the requisite holders of the Series D Preferred Stock, amend Section 6(d) of the Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock (the “Series D Certificate”) to increase the Beneficial Ownership Limitation, as defined in the Series D Certificate, from 9.99% to 49.9% and (iii) amend Section 2(e) of each of the O’Neill Trust’s Series D A Warrant and Series E A Warrant and Section 2(d) of the O’Neill Trust’s Series E B Warrant to increase the Beneficial Ownership Limitation Ceiling from 25% to 49.9%.          
Common stock voting rights thresold percentage   49.90%